Published date: 11 April 2025

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 9 October 2023, 1pm

Contract summary

Industry

  • Vaccines - 33651600

Location of contract

E14 4PU

Value of contract

£1

Procurement reference

CF-2968300D0O000000rwimUAA

Published date

11 April 2025

Closing date

9 October 2023

Closing time

1pm

Contract start date

1 October 2025

Contract end date

30 September 2030

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of low dose diphtheria tetanus and inactivated polio vaccine to be used as part of the national immunisation programme.
Deliveries will be required over a period of 3 years, with an option to extend for up to an additional 24 months.
Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
The opportunity is not split into lots as the requirement is for a specific vaccine.

More information

Attachments

Award information

Awarded date

19 March 2025

Contract start date

1 October 2025

Contract end date

30 September 2030

Total value of contract

£1

This contract was awarded to 1 supplier.

Aventis Pharma ltd t/a Sanofi

Address

410 Thames Valley Park Drive, Reading, RG6 1PT

Reference

None

Supplier is SME?

No

About the buyer

Contact name

Chantal Jockel

Address

10 South Colonnade
London
E14 4PU
GB

Email

vmc.vaccines@ukhsa.gov.uk